Dr. reddy's included in s&p global's sustainability yearbook for the 2nd year and bloomberg gender-equality index for the 5th year in a row

Hyderabad, india--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy, hereafter referred to as “dr. reddy's”) announces two major back-to-back recognitions in sustainability and gender equality. dr. reddy's is one of seven indian companies in bloomberg's gender-equality index (gei) 2022, and the only indian pharma company in the index. the 2022 gei comprises 418 companies across 45 countries with a combined market capitalisation of $16 trillio
RDY Ratings Summary
RDY Quant Ranking